Supplemental insurance firm Aflac's Q3 revenue beats expectations

Aflac

04/11/2025 21:57

Overview

Aflac Q3 revenue of $4.7 bln beats analyst expectations

Adjusted EPS for Q3 beats consensus, rising 15.3% to $2.49

Company repurchased $1.0 bln in shares during Q3

Outlook

Company did not provide specific future guidance

Result Drivers

NET INVESTMENT GAINS - Aflac's Q3 results were driven by net investment gains of $275 mln, reversing prior year losses

STRONG JAPAN SALES - Aflac Japan's sales increased 11.8% due to strong performance of new cancer insurance product Miraito

U.S. PREMIUM GROWTH - Aflac U.S. net earned premiums rose 2.5% in Q3, driven by improved sales of group life and disability products

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$4.70 bln
$4.38 bln (6 Analysts)
Q3 Adjusted EPS
Beat
$2.49
$1.77 (13 Analysts)
Q3 EPS
$3.08
Q3 Adjusted Net Income
Beat
$1.30 bln
$955.97 mln (8 Analysts)
Q3 Net Income
$1.60 bln


Press Release: ID:nPn6GlJpca

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)